John Alexander Kelly - 28 Feb 2023 Form 4 Insider Report for PRECISION BIOSCIENCES INC (DTIL)

Role: Chief Financial Officer
Signature: /s/ Dario Scimeca, Attorney-in-fact for John Alexander Kelly
Issuer symbol: DTIL
Transactions as of: 28 Feb 2023
Net transactions value: +$11,025
Form type: 4
Filing time: 07 Mar 2023, 16:08:45 UTC
Previous filing: 24 Jan 2023
Next filing: 21 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DTIL	Common Stock	Award	$11,025	+11,605	+7.1%	$0.9500	174,543	28 Feb 2023	Direct
transaction	DTIL	Common Stock	Options Exercise		+51,071	+29%		225,614	03 Mar 2023	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DTIL	Restricted Stock Units	Options Exercise	$0	-51,071	-33%	$0.000000	102,114	03 Mar 2023	Common Stock	51,071		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on March 3, 2023.
F2	Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F3	On March 3, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.